New subset of retinal neurons with an impact on vision is discovered by research.

Published Date: 25 Oct 2023

Researchers at Northwestern Medicine have reported in Nature that they have identified a novel subtype of interneurons in the retina that improves the eye's ability to perceive and distinguish objects in both light and dark environments.

Read Full News

Latest News

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Latest News

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

News All Time

Loss of Payment Assistance for AMD Drugs Strains Patients and Ophthalmologists

— Pervasive "unsustainable" clinical practices amid cat-and-mouse game with funding availability

Mindfulness App Eases Mental Burden in Eye Disease

A digital mindfulness-based intervention significantly reduces symptoms of anxiety and depression and perceived stress in adults with noninfectious uveitis, a clinical trial shows.

Families Traveling for Uveitis Screenings Face Higher Costs

Patients who lived more than 30 miles away from their specialists had median annual expenses over $400 in Tennessee and over $300 in California.

A Faster Path to an Artificial Eye

3D printing can greatly improve access to the prosthetics.

Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss.

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Navigating Sustained Delivery in DME: An Interactive Clinical Decision-Making Simulation

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

AAO: American Academy of Ophthalmology

ASRS: American Society of Retina Specialists

ARVO Video Pearls: Video Pearls From The Association for Research in Vision and Ophthalmology

Trump Showing His Age? Nasal Spray Recalled; Elton John on Losing Sight

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

Study offers clearer picture of childhood brain tumor survival

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

Oncology Drug Shortages Persist, but Continue to Evolve

Recommended Articles For You

Progressive Updates in Oncology for Healthcare Excellence 

Gene Therapy for Hemophilia: A New Hope on the Horizon 

The Cutting-Edge of Phlebectomy: Redefining Vein Care 

Critical Care Updates on Hematopoietic Dysfunction During Prolonged Critical Illness 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belgian Algorithm Reshapes Endometrial Cancer Care

2.

ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer

3.

Nuclear missile workers are contracting cancer: They blame the bases

4.

On all CAR-T products, the FDA is calling for a new boxed warning.

5.

ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology

1.

Understanding SVR Normal Range: A Guide to Achieving Optimal Health

2.

Consensus Recommendations for Healthy Hematologic Aging

3.

The Role of Alanine Aminotransferase in Liver Health and Disease 

4.

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers

5.

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Efficient Management of First line ALK-rearranged NSCLC - Part II

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

4.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

5.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot